Related references
Note: Only part of the references are listed.The PPARgamma agonist pioglitazone inhibits early neoplastic occurrence in the rat liver
I. Borbath et al.
EUROPEAN JOURNAL OF CANCER (2007)
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis
Vincenzo Mazzaferro et al.
HEPATOLOGY (2006)
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Renata Belfort et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Limited therapeutic efficacy of pioglitazone on progression of hepatic fibrosis in rats
I. A. Leclercq et al.
GUT (2006)
Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo
J Yu et al.
HEPATOLOGY (2006)
The selective cyclooxygenase-2 inhibitor SC-236 reduces liver fibrosis by mechanisms involving non-parenchymal cell apoptosis and PPARγ activation
A Planagumà et al.
FASEB JOURNAL (2005)
Peroxisome proliferator-activated receptor γ inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells
KL Schaefer et al.
CANCER RESEARCH (2005)
Peroxisome proliferator-activated receptor γ induces a phenotypic switch from activated to quiescent hepatic stellate cells
S Hazra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet
K Kawaguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Peroxisome proliferator-activated receptor γ ligands, 15-deoxy-Δ12,14-prostagiandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells
JD Cheng et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Peroxisome-proliferator-activated receptors and cancers: Complex stories
L Michalik et al.
NATURE REVIEWS CANCER (2004)
Growth arrest by troglitazone is mediated by p27(Kip1) accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells
W Motomura et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Lack of efficacy of troglitazone at clinically achievable concentrations, with or without 9-cis retinoic acid or cytotoxic agents, for hepatocellular carcinoma cell lines
YC Shen et al.
BRITISH JOURNAL OF CANCER (2004)
15-Deoxy-Δ-12-14-PGJ2 regulates apoptosis induction and nuclear factor-κB activation via a peroxisome proliferator-activated receptor-γ-independent mechanism in hepatocellular carcinoma
H Okano et al.
LABORATORY INVESTIGATION (2003)
Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells
MY Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
PPARγ pathway activation results in apoptosis and COX-2 inhibition in HepG2 cells
MY Li et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Troglitazone induces p27Kip1-associated cell-cycle arrest through down-regulating Skp2 in human hepatoma cells
H Koga et al.
HEPATOLOGY (2003)
Peroxisome proliferator-activated receptor γ ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines
K Yoshizawa et al.
CANCER (2002)
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro
A Galli et al.
GASTROENTEROLOGY (2002)
A ligand for peroxisome proliferator activated receptor γ inhibits cell growth and induces apoptosis in human liver cancer cells
M Toyoda et al.
GUT (2002)
Peroxisome proliferator-activated receptor gamma augments tumor necrosis factor family-induced apoptosis in hepatocellular carcinoma
H Okano et al.
ANTI-CANCER DRUGS (2002)
Cytotoxicity and apoptosis produced by troglitazone in human hepatoma cells
Y Yamamoto et al.
LIFE SCIENCES (2001)
Peroxisome proliferator-activated receptor γ ligand-induced growth inhibition of human hepatocellular carcinoma
MAK Rumi et al.
BRITISH JOURNAL OF CANCER (2001)
Involvement of p21WAF1/Cip1, p27Kip1, and p18INK4c in troglitazone-induced cell-cycle arrest in human hepatoma cell lines
H Koga et al.
HEPATOLOGY (2001)
Share Paper
